Immunotherapies for Infectious Diseases Congress 2018 (I4ID2018)
10-11 December 2018, Lyon – France
The 2nd Immunotherapies for Infectious Diseases Congress 2018 (I4ID2018), organized by MabDesign and BIOASTER, will bring together pharmaceutical industries, research labs, clinicians, service providers, technology developers, and policymakers to exchange about the development of immunotherapy solutions for prevention and treatment of infectious diseases.
The Scientific Committee has set-up an exciting program for the I4ID 2018 Congress, focusing on “Host-Directed Therapies to fight Infectious Diseases” that includes keynote lectures, pitch talks of new creative projects, and industrial talks from big pharmaceutical companies. The I4ID 2018 Congress program also contains several opportunities for networking and dedicated time for business partnering.
The topics covered during this meeting are:
CALL FOR ABSTRACTS – Deadline 28th September 2018
You work in the field of infectious diseases and you have an innovation to share concerning Host-Directed Therapies or immunotherapies?
Are you part of an SME / start-up/research laboratory? Do you want to share your expertise?
Share your innovative products, new technologies and research projects at the Pitch Session “Innovation on HDT approaches to treat Infectious diseases” or during the Poster session! Check the guidelines to submit your abstract: http://www.i4id.org/abstracts.php
This is a great opportunity for start-ups, SMEs, and academic laboratories to share their new work!
Early Bird Registration until 5th October 2018 – register early to secure the best rates!
MabDesign members have a 20% discount on the registration fee.
Register now: http://www.i4id.org/register.php
For more details on the program and to register please visit the website: http://www.i4id.org
This content is blocked. Accept cookies to view the content.